SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes
Ever since the first case was reported at the end of 2019, the SARS-COV-2 virus and associated lung disease COVID-19 has spread throughout the world and has become a pandemic. In particular, the high transmission rate of the virus has made it a threat to public health globally. Currently, there is no proven effective therapy against the virus, and the impact on other diseases is also uncertain, especially inherited arrhythmia syndrome.Arrhythmogenic effect of COVID-19 can be expected, potentially contributing to disease outcome.
Source: Heart Rhythm - Category: Cardiology Authors: Cheng-I. Wu, Pieter G. Postema, Elena Arbelo, Elijah R. Behr, Connie R. Bezzina, Carlo Napolitano, Tomas Robyns, Vincent Probst, Eric Schulze-Bahr, Carol Ann Remme, Arthur A.M. Wilde Source Type: research
More News: Arrhythmia | Cardiology | COVID-19 | Heart | International Medicine & Public Health | Pandemics | SARS